Seminars in Hematology
Volume 44, Supplement 1 , Pages 4-14, January 2007

The Biology of Chronic Myelogenous Leukemia: Implications for Imatinib Therapy

  • Ricardo H. Alvarez

      Affiliations

    • Division of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX.
    • ,
  • Hagop Kantarjian

      Affiliations

    • Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX.
    • ,
  • Jorge E. Cortes

      Affiliations

    • Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX.
    • Corresponding Author InformationAddress correspondence to Jorge E. Cortes, MD, Professor of Medicine, Department of Leukemia, Unit 428, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030-4009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0037-1963(06)00260-5

doi:10.1053/j.seminhematol.2006.12.007

Seminars in Hematology
Volume 44, Supplement 1 , Pages 4-14, January 2007

Article Tools

* Image Usage & Resolution